Reviva Pharmaceuticals Holdi
RVPHBiotechnology
$0.39−5.66%As of Oct 29vs prior close
- Market cap
- $5.1M
- P/E (TTM)
- –
- From 52W high
- −97.32%
- EPS (LTM)
- -$1.12
- Dividend yield
- 0.00%
Nomior Score
24
Steady ProfileSpeculativeBottom 10% of the scored universe
Growth—
Quality39
Value—
Momentum14
Resilience27